Suivez-nous sur les réseaux sociaux !

Retrouvez les articles immanquables des Archives of Cardiovascular Diseases, revue scientifique mensuelle en anglais de notoriété internationale.

Voici un aperçu rapide des sujets abordés dans cette publication :

Accédez à l’intégralité de nos revues et de notre veille bibliographique !

En devenant membre SFC, vous recevez chaque mois nos revues et chaque semaine notre veille bibliographique complète.

Dernières publications

Toute l’actualité scientifique en cardiologie sur Cardio-online, le site d’information et de formation de la SFC !

Publications

Clinical Research – Redo surgical aortic valve replacement: An outdated technique in the era of valve-in-valve procedures?

By Published On: 15/10/2025

Voici un aperçu rapide des sujets abordés dans cette publication :

Archives of Cardiovascular Diseases | Septembre 2025

Johannes Petersen, Roman Stiefel, Sumi Westhofen, Eik Vettorazzi, Till Demal, Beate Reiter, Björn Sill, Lenard Conradi, Yousuf Al Assar, Hermann Reichenspurner, Christian Detter

Abstract

Background: The treatment of degenerative prosthetic aortic valves is increasingly important. However, redo surgical aortic valve replacement (Re-SAVR) carries higher perioperative risks than primary surgical aortic valve replacement.

Aim: This study aims to identify predictors of early morbidity and death after Re-SAVR.

Methods: A retrospective analysis of 220 patients scheduled for elective Re-SAVR between 2009 and 2017 was conducted. Patients were divided into isolated (n = 87) and combined (n = 133) redo procedures. The primary endpoint was in-hospital death, and secondary endpoints were postoperative complications, such as stroke, dialysis and pacemaker implantation. Regression analysis identified independent predictors of death.

Results: Among the patients undergoing Re-SAVR (mean age, 62.6 ± 13.2 years; 71% male; mean EuroSCORE II, 12.6 ± 11.1%), 86.4% received biological prostheses and 13.6% received mechanical pros-theses. The in-hospital death rate was 5.7% for isolated Re-SAVR and 18.0% for combined procedures (P = 0.003). Excluding patients with endocarditis, the in-hospital death rate was 0% for isolated Re-SAVR and 19.7% for combined procedures (P = 0.002). The incidence of postoperative complications after an isolated procedure was similar to that after a combined procedure. Independent predictors of 30-day death were previous coronary artery bypass grafting (odds ratio: 14.12, 95% confidence interval: 4.40–51.35;P < 0.001), a combined procedure (odds ratio: 7.01, 95% confidence interval: 2.09–31.54; P = 0.004) and New York Heart Association functional class III/IV (odds ratio: 3.73, 95% confidence interval: 1.31–12.58;P = 0.020).

Conclusions: The perioperative risk of death after isolated Re-SAVR in patients without endocarditiswas 0%. Independent predictors of in-hospital death included previous coronary artery bypass graft-ing, combined procedures and New York Heart Association class III/IV. These findings may inform thedecision-making process of the heart

Keywords

  • Redo surgery

  • Aortic valve surgery
  • Valve-in-valve procedure

Table of contents

  • Abbreviations
  • Background
  • Methods
  • Results
  • Discussion
  • Conclusions

© 2025 Elsevier Masson SAS. Tous droits réservés.

Partagez cet article :

Partagez cet article :

Written by : SFC

Plus de publications de la SFC

Devenez membre SFC !

Les membres de la SFC ont accès à de nombreux avantages exclusifs :

  • Intégrer la communauté de sa surspécialité

  • Participer aux JESFC à un tarif préférentiel

  • Recevoir les revues d’expression de la SFC

  • Candidater aux prix et bourses

  • Bénéficier d’un accès complet à Cardio-online

  • S’assurer une affiliation à l’ESC

  • Avoir accès à l’actualité en cardiologie

  • Diffuser vos offres d’emploi